Surgical implications of mesenteric lymph node metastasis from advanced ovarian cancer after bowel resection
Corresponding Author
Glauco Baiocchi MSc, MD
Department of Gynecologic Oncology, AC Camargo Cancer Hospital, Sao Paulo, Brazil
Departamento de Ginecologia, Hospital do Cancer AC Camargo, Rua Antonio Prudente, 211, 01509-010, São Paulo, Brazil. Fax: +55-11-2114-6072.Search for more papers by this authorLourival Augusto Cestari MD
Department of Gynecologic Oncology, AC Camargo Cancer Hospital, Sao Paulo, Brazil
Search for more papers by this authorMariana Petaccia Macedo MD
Department of Pathology, AC Camargo Cancer Hospital, Sao Paulo, Brazil
Search for more papers by this authorRenato Almeida Rosa Oliveira MD
Department of Gynecologic Oncology, AC Camargo Cancer Hospital, Sao Paulo, Brazil
Search for more papers by this authorElza Mieko Fukazawa MSc, MD
Department of Gynecologic Oncology, AC Camargo Cancer Hospital, Sao Paulo, Brazil
Search for more papers by this authorCarlos Chaves Faloppa MD
Department of Gynecologic Oncology, AC Camargo Cancer Hospital, Sao Paulo, Brazil
Search for more papers by this authorLillian Yuri Kumagai MD
Department of Gynecologic Oncology, AC Camargo Cancer Hospital, Sao Paulo, Brazil
Search for more papers by this authorLevon Badiglian-Filho MD, PhD
Department of Gynecologic Oncology, AC Camargo Cancer Hospital, Sao Paulo, Brazil
Search for more papers by this authorAdemir Narciso Oliveira Menezes MD
Department of Gynecologic Oncology, AC Camargo Cancer Hospital, Sao Paulo, Brazil
Search for more papers by this authorIsabela Werneck Cunha MD, PhD
Department of Pathology, AC Camargo Cancer Hospital, Sao Paulo, Brazil
Search for more papers by this authorFernando Augusto Soares MD, PhD
Department of Pathology, AC Camargo Cancer Hospital, Sao Paulo, Brazil
Search for more papers by this authorCorresponding Author
Glauco Baiocchi MSc, MD
Department of Gynecologic Oncology, AC Camargo Cancer Hospital, Sao Paulo, Brazil
Departamento de Ginecologia, Hospital do Cancer AC Camargo, Rua Antonio Prudente, 211, 01509-010, São Paulo, Brazil. Fax: +55-11-2114-6072.Search for more papers by this authorLourival Augusto Cestari MD
Department of Gynecologic Oncology, AC Camargo Cancer Hospital, Sao Paulo, Brazil
Search for more papers by this authorMariana Petaccia Macedo MD
Department of Pathology, AC Camargo Cancer Hospital, Sao Paulo, Brazil
Search for more papers by this authorRenato Almeida Rosa Oliveira MD
Department of Gynecologic Oncology, AC Camargo Cancer Hospital, Sao Paulo, Brazil
Search for more papers by this authorElza Mieko Fukazawa MSc, MD
Department of Gynecologic Oncology, AC Camargo Cancer Hospital, Sao Paulo, Brazil
Search for more papers by this authorCarlos Chaves Faloppa MD
Department of Gynecologic Oncology, AC Camargo Cancer Hospital, Sao Paulo, Brazil
Search for more papers by this authorLillian Yuri Kumagai MD
Department of Gynecologic Oncology, AC Camargo Cancer Hospital, Sao Paulo, Brazil
Search for more papers by this authorLevon Badiglian-Filho MD, PhD
Department of Gynecologic Oncology, AC Camargo Cancer Hospital, Sao Paulo, Brazil
Search for more papers by this authorAdemir Narciso Oliveira Menezes MD
Department of Gynecologic Oncology, AC Camargo Cancer Hospital, Sao Paulo, Brazil
Search for more papers by this authorIsabela Werneck Cunha MD, PhD
Department of Pathology, AC Camargo Cancer Hospital, Sao Paulo, Brazil
Search for more papers by this authorFernando Augusto Soares MD, PhD
Department of Pathology, AC Camargo Cancer Hospital, Sao Paulo, Brazil
Search for more papers by this authorAbstract
Background
Studies addressing mesenteric and mesocolic lymph node metastasis in patients with advanced ovarian cancer that have undergone bowel resection are lacking.
Methods
A retrospective analysis was performed in a series of 50 individuals who underwent surgical cytoreduction for epithelial ovarian cancer that included bowel resection from April 2004 to September 2010.
Results
Forty-one patients had bowel resection with mesenteric lymph nodes that were suitable for analysis. Twenty-four (58.5%) patients underwent retosigmoidectomies, 14 (34.1%) received other types of colectomies, and three (7.3%) underwent small bowel resection. There was serosal involvement in 14 cases (34.1%), muscularis propria invasion in 13 cases (31.7%), submucosa invasion in six cases (14.6%), and mucosa in eight cases (19.5%). Lymphatic invasion was observed in 24 patients (58.5%). A median of 14 mesenteric lymph nodes were analyzed. Metastatic lymph nodes were observed in 29 (70.7%) cases. Invasion into the muscularis propria (P = 0.036), lymphatic invasion (P = 0.045), and retroperitoneal lymph node metastasis (P = 0.002) correlated significantly with mesenteric lymph node involvement.
Conclusions
Resection of regional lymph nodes of affected organs that is similar to surgical procedures that are performed for colorectal carcinoma is an appropriate, optimal debulking surgery for patients with ovarian carcinoma. J. Surg. Oncol. 2011; 104:250–254. © 2011 Wiley-Liss, Inc.
REFERENCES
- 1 Jemal A, Siegel R, Xu J, et al.: Cancer statistics, 2010. CA Cancer J Clin 2010; 60: 277–300.
- 2 Delgado G, Oram DH, Petrilli ES: Stage III epithelial ovarian cancer: The role of maximal surgical reduction. Gynecol Oncol 1984; 18: 293–298.
- 3 Hoskins WJ, McGuire WP, Brady MF, et al.: The effect of diameter of largest residual disease on survival after primary cytoreductive surgery in patients with suboptimal residual epithelial ovarian carcinoma. Am J Obstet Gynecol 1994; 170: 974–979.
- 4 Hacker NF, Berek JS, Lagasse LD, et al.: Primary cytoreductive surgery for epithelial ovarian cancer. Obstet Gynecol 1983; 61: 413–420.
- 5 Chi DS, Liao JB, Leon LF, et al.: Identification of prognostic factors in advanced epithelial ovarian carcinoma. Gynecol Oncol 2001; 82: 532–537.
- 6 Piver MS, Lele SB, Marchetti DL, et al.: The impact of aggressive debulking surgery and cisplatin-based chemotherapy on progression-free survival in stage III and IV ovarian carcinoma. J Clin Oncol 1988; 6: 983–989.
- 7 Vergote I, Tropé CG, Amant F, et al.: Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer. N Engl J Med 2010; 363: 943–953.
- 8 du Bois A, Reuss A, Pujade-Lauraine E, et al.: Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: A combined exploratory analysis of 3 prospectively randomized phase 3 multicenter trials: By the Arbeitsgemeinschaft Gynaekologische Onkologie Studiengruppe Ovarialkarzinom (AGO-OVAR) and the Groupe d'Investigateurs Nationaux Pour les Etudes des Cancers de l'Ovaire (GINECO). Cancer 2009; 115: 1234–1244.
- 9 Eisenkop SM, Friedman RL, Wang HJ: Complete cytoreductive surgery is feasible and maximizes survival in patients with advanced epithelial ovarian cancer: A prospective study. Gynecol Oncol 1998; 69: 103–108.
- 10 Aletti GD, Dowdy SC, Gostout BS, et al.: Aggressive surgical effort and improved survival in advanced-stage ovarian cancer. Obstet Gynecol 2006; 107: 77–85.
- 11 Eisenhauer EL, Abu-Rustum NR, Sonoda Y, et al.: The effect of maximal surgical cytoreduction on sensitivity to platinum-taxane chemotherapy and subsequent survival in patients with advanced ovarian cancer. Gynecol Oncol 2008; 108: 276–281.
- 12 Chi DS, Eisenhauer EL, Lang J, et al.: What is the optimal goal of primary cytoreductive surgery for bulky stage IIIC epithelial ovarian carcinoma (EOC)? Gynecol Oncol 2006; 103: 559–564.
- 13 Bristow RE, del Carmen MG, Kaufman HS, et al.: Radical oophorectomy with primary stapled colorectal anastomosis for resection of locally advanced epithelial ovarian cancer. J Am Coll Surg 2003; 197: 565–574.
- 14 Spirtos NM, Eisenkop SM, Schlaerth JB, et al.: Second-look laparotomy after modified posterior exenteration: Patterns of persistence and recurrence in patients with stage III and stage IV ovarian cancer. Am J Obstet Gynecol 2000; 182: 1321–1327.
- 15 Mourton SM, Temple LK, Abu-Rustum NR, et al.: Morbidity of rectosigmoid resection and primary anastomosis in patients undergoing primary cytoreductive surgery for advanced epithelial ovarian cancer. Gynecol Oncol 2005; 99: 608–614.
- 16 Berek JS, Hacker NF, Lagasse LD: Rectosigmoid colectomy and reanastomosis to facilitate resection of primary and recurrent gynecologic cancer. Obstet Gynecol 1984; 64: 715–720.
- 17 Eisenkop SM, Nalick RH, Teng NN: Modified posterior exenteration for ovarian cancer. Obstet Gynecol 1991; 78: 879–885.
- 18
Scarabelli C,
Gallo A,
Franceschi S, et al.:
Primary cytoreductive surgery with rectosigmoid colon resection for patients with advanced epithelial ovarian carcinoma.
Cancer
2000;
88:
389–397.
10.1002/(SICI)1097-0142(20000115)88:2<389::AID-CNCR21>3.0.CO;2-W CAS PubMed Web of Science® Google Scholar
- 19 Tamussino KF, Lim PC, Webb MJ, et al.: Gastrointestinal surgery in patients with ovarian cancer. Gynecol Oncol 2001; 80: 79–84.
- 20 Hoffman MS, Griffin D, Tebes S, et al.: Sites of bowel resected to achieve optimal ovarian cancer cytoreduction: Implications regarding surgical management. Am J Obstet Gynecol 2005; 193: 582–586.
- 21 Hertel H, Diebolder H, Herrmann J, et al.: Is the decision for colorectal resection justified by histopathologic findings: A prospective study of 100 patients with advanced ovarian cancer. Gynecol Oncol 2001; 83: 481–484.
- 22 Cecil TD, Sexton R, Moran BJ, et al.: Total mesorectal excision results in low local recurrence rates in lymph node-positive rectal cancer. Dis Colon Rectum 2004; 47: 1145–1149.
- 23 MacFarlane JK, Ryall RD, Heald RJ: Mesorectal excision for rectal cancer. Lancet 1993; 341: 457–460.
- 24 André T, Boni C, Mounedji-Boudiaf L, et al.: Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. N Engl J Med 2004; 350: 2343–2351.
- 25 Griffiths CT, Parker LM, Fuller AF, Jr: Role of cytoreductive surgical treatment in the management of advanced ovarian cancer. Cancer Treat Rep 1979; 63: 235–240.
- 26 Fader AN, Rose PG: Role of surgery in ovarian carcinoma. J Clin Oncol 2007; 25: 2873–2883.
- 27 Bristow RE, Tomacruz RS, Armstrong DK, et al.: Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: A meta-analysis. J Clin Oncol 2002; 20: 1248–1259.
- 28 Di Re F, Baiocchi G: Value of lymph node assessment in ovarian cancer: Status of the art at the end of the second millennium. Int J Gynecol Cancer 2000; 10: 435–442.
- 29 Burghardt E, Pickel H, Lahousen M, et al.: Pelvic lymphadenectomy in operative treatment of ovarian cancer. Am J Obstet Gynecol 1986; 155: 315–319.
- 30 Kigawa J, Minagawa Y, Itamochi H, et al.: Retroperitoneal lymphadenectomy, including the para-aortic nodes in patients with stage III ovarian cancer. Am J Clin Oncol 1994; 17: 230–233.
- 31 Spirtos NM, Gross GM, Freddo JL, et al.: Cytoreductive surgery in advanced epithelial cancer of the ovary: The impact of aortic and pelvic lymphadenectomy. Gynecol Oncol 1995; 56: 345–352.
- 32 di Re F, Baiocchi G, Fontanelli R, et al.: Systematic pelvic and paraaortic lymphadenectomy for advanced ovarian cancer: Prognostic significance of node metastases. Gynecol Oncol 1996; 62: 360–365.
- 33 Chan JK, Munro EG, Cheung MK, et al.: Association of lymphadenectomy and survival in stage I ovarian cancer patients. Obstet Gynecol 2007; 109: 12–19.
- 34 Chan JK, Urban R, Hu JM, et al.: The potential therapeutic role of lymph node resection in epithelial ovarian cancer: A study of 13918 patients. Br J Cancer 2007; 96: 1817–1822.
- 35 Panici PB, Maggioni A, Hacker N, et al.: Systematic aortic and pelvic lymphadenectomy versus resection of bulky nodes only in optimally debulked advanced ovarian cancer: A randomized clinical trial. J Natl Cancer Inst 2005; 97: 560–566.
- 36 Eisenkop SM, Spirtos NM: Procedures required to accomplish complete cytoreduction of ovarian cancer: Is there a correlation with “biological aggressiveness” and survival? Gynecol Oncol 2001; 82: 435–441.
- 37 Gillette-Cloven N, Burger RA, Monk BJ, et al.: Bowel resection at the time of primary cytoreduction for epithelial ovarian cancer. J Am Coll Surg 2001; 193: 626–632.
- 38 Aletti GD, Podratz KC, Jones MB, et al.: Role of rectosigmoidectomy and stripping of pelvic peritoneum in outcomes of patients with advanced ovarian cancer. J Am Coll Surg 2006; 203: 521–526.
- 39 Tebes SJ, Cardosi R, Hoffman MS: Colorectal resection in patients with ovarian and primary peritoneal carcinoma. Am J Obstet Gynecol 2006; 195: 585–589.
- 40
Abrams HL,
Spiro R,
Goldstein N:
Metastases in carcinoma; analysis of 1000 autopsied cases.
Cancer
1950;
3:
74–85.
10.1002/1097-0142(1950)3:1<74::AID-CNCR2820030111>3.0.CO;2-7 CAS PubMed Web of Science® Google Scholar
- 41 Wu PC, Lang JH, Huang RL, et al.: Intestinal metastasis and operation in ovarian cancer: A report on 62 cases, Baillieres Clin. Obstet. Gynaecol 1989; 3: 95–108.
- 42 Dvoretsky PM, Richards KA, Angel C, et al.: Distribution of disease at autopsy in 100 women with ovarian cancer. Hum Pathol 1988; 19: 57–63.
- 43 O'Hanlan KA, Kargas S, Schreiber M, et al.: Ovarian carcinoma metastases to gastrointestinal tract appear to spread like colon carcinoma: Implications for surgical resection. Gynecol Oncol 1995; 59: 200–206.
- 44 Salani R, Diaz-Montes T, Giuntoli RL, et al.: Surgical management of mesenteric lymph node metastasis in patients undergoing rectosigmoid colectomy for locally advanced ovarian carcinoma. Ann Surg Oncol 2007; 14: 3552–3557.
- 45
Musumeci R,
Banfi A,
Bolis G, et al.:
Lymphangiography in patients with ovarian epithelial cancer: An evaluation of 289 consecutive cases.
Cancer
1977;
40:
1444–1449.
10.1002/1097-0142(197710)40:4<1444::AID-CNCR2820400414>3.0.CO;2-I CAS PubMed Web of Science® Google Scholar
- 46 Bouwman DL, Weaver DW: Colon cancer: Surgical therapy. Gastroenterol Clin North Am 1988; 17: 859–872.
- 47 McDaniel KP, Charnsangavej C, DuBrow RA, et al.: Pathways of nodal metastasis in carcinomas of the cecum, ascending colon, and transverse colon: CT demonstration. AJR Am J Roentgenol 1993; 161: 61–64.
- 48 Crucitti F, Doglietto GB, Bellantone R, et al.: Accurate specimen preparation and examination is mandatory to detect lymph nodes and avoid understaging in colorectal cancer. J Surg Oncol 1992; 51: 153–157.
- 49 Lowden S, Heath T: Lymphatic drainage from the distal small intestine in sheep. J Anat 1993; 183: 13–20.
